Clinical trial
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate…
NCT00003084 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003084 |
|---|---|
| Title | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer |
| Official title | A Randomized Phase II Trial of Taxol/VP-16/Estramustine vs. Ketoconazole/Doxorubicin/Vinblastine/Estramustine in Androgen Independent Prostate Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Doxorubicin Hydrochloride, Estramustine phosphate sodium, Etoposide, Ketoconazole, Paclitaxel, Vinblastine |
| Enrollment | 75 |
| Start date | Dec 1, 1997 |
| Primary completion | Nov 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | May 24, 2004 |
| Last update posted | Jul 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: